AktieNasdaqGSPODD
Insulet Corporation
$135.78
-2.10 (-1.52%)today
Bewertung & Gewinn
- KGV
- 25,57
- Forward-KGV
- 17,62
- Gewinn je Aktie (ttm)
- 5,31 $
- Erwarteter Gewinn je Aktie
- 7,71 $
- Kurs-Buchwert-Verhältnis
- 6,62
- PEG-Ratio
- 1,07
- Ausschüttungsquote
- 0 %
Finanzkennzahlen (ttm)
- Umsatz (ttm)
- 3,1 Mrd.
- Umsatzwachstum
- 23,5 %
- Gewinnmarge
- 12,29 %
- Eigenkapitalrendite
- 26,02 %
- Liquide Mittel
- 534,9 Mio.
- Verschuldung
- 948,4 Mio.
Ergebnisse (Gewinn je Aktie)
| Quartal | Erwartet | Tatsächlich | Überraschung |
|---|---|---|---|
| 30. Sept. 2025 | 1,15 | 1,24 | +8,07 % |
| 31. Dez. 2025 | 1,46 | 1,55 | +5,97 % |
| 31. März 2026 | 1,19 | 1,42 | +19,26 % |
| 30. Juni 2026 | 1,45 | 1,66 | +14,28 % |
Nächster Ergebnistermin: 5. Nov. 2026
Analystensicht
Konsens-RatingKaufen25 Analysten
Starker Kauf 4Kaufen 11Halten 10
Kursziele (12 Monate)Implizites Potenzial: +26,61 %
144
171,91
275
TiefAktueller KursHoch
Aktuelle Nachrichten
(Englisch)How Is Insulet's Stock Performance Compared to Other Medical Devices Stocks?
Barchart24. Sept. 2026
BCSM Exits Insulet Corporation (PODD), Maintains Watchlist Status
Insider Monkey17. Sept. 2026
2 S&P 500 Stocks with Impressive Fundamentals and 1 We Turn Down
StockStory14. Sept. 2026
Why Pay More For Stryker When BSX Stock Is On Sale?
Trefis14. Sept. 2026
Beta Bionics’ insulin patch pump gets FDA nod
MedTech Dive14. Sept. 2026
Is it Prudent to Retain Insulet Stock in Your Portfolio for Now?
Zacks8. Sept. 2026
Ähnliche Produkte
How visible is Insulet Corporation in AI search?
We ask AI search engines about Insulet Corporation and its market — live — and measure whether and how prominently the brand appears in their answers.
No AI visibility check has been run for Insulet Corporation yet.
Run a live check to see how AI search engines talk about this brand right now.
Is your brand this visible in AI search?
Aurora tracks your brand across 7 AI search engines — visibility, share of voice and the sources that shape AI answers.